{"id":5240,"date":"2011-11-09T18:47:01","date_gmt":"2011-11-09T18:47:01","guid":{"rendered":"https:\/\/e-algos.com\/%ce%be%ce%b5%ce%ba%ce%b9%ce%bd%ce%ac%ce%b5%ce%b9-%ce%b7-%ce%b4%ce%bf%ce%ba%ce%b9%ce%bc%ce%ae-%cf%84%ce%bf%cf%85-%cf%86%ce%b1%cf%81%ce%bc%ce%ac%ce%ba%ce%bf%cf%85-avp-923-%ce%b3%ce%b9%ce%b1-%cf%84%ce%bf\/"},"modified":"2024-12-15T17:03:59","modified_gmt":"2024-12-15T17:03:59","slug":"%ce%be%ce%b5%ce%ba%ce%b9%ce%bd%ce%ac%ce%b5%ce%b9-%ce%b7-%ce%b4%ce%bf%ce%ba%ce%b9%ce%bc%ce%ae-%cf%84%ce%bf%cf%85-%cf%86%ce%b1%cf%81%ce%bc%ce%ac%ce%ba%ce%bf%cf%85-avp-923-%ce%b3%ce%b9%ce%b1-%cf%84%ce%bf","status":"publish","type":"post","link":"https:\/\/e-algos.com\/el\/%ce%be%ce%b5%ce%ba%ce%b9%ce%bd%ce%ac%ce%b5%ce%b9-%ce%b7-%ce%b4%ce%bf%ce%ba%ce%b9%ce%bc%ce%ae-%cf%84%ce%bf%cf%85-%cf%86%ce%b1%cf%81%ce%bc%ce%ac%ce%ba%ce%bf%cf%85-avp-923-%ce%b3%ce%b9%ce%b1-%cf%84%ce%bf\/","title":{"rendered":"\u039e\u03b5\u03ba\u03b9\u03bd\u03ac\u03b5\u03b9 \u03b7 \u0394\u03bf\u03ba\u03b9\u03bc\u03ae \u03c4\u03bf\u03c5 \u03a6\u03b1\u03c1\u03bc\u03ac\u03ba\u03bf\u03c5 AVP-923 \u03b3\u03b9\u03b1 \u03c4\u03bf\u03bd \u039a\u03b5\u03bd\u03c4\u03c1\u03b9\u03ba\u03cc \u039d\u03b5\u03c5\u03c1\u03bf\u03c0\u03b1\u03b8\u03b7\u03c4\u03b9\u03ba\u03cc \u03a0\u03cc\u03bd\u03bf \u03c3\u03b5 \u0391\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03a3\u03ba\u03bb\u03ae\u03c1\u03c5\u03bd\u03c3\u03b7 \u039a\u03b1\u03c4\u03ac \u03a0\u03bb\u03ac\u03ba\u03b1\u03c2."},"content":{"rendered":"<p><a href=\"https:\/\/www.e-algos.com\/wp-content\/uploads\/2011\/11\/AVP.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-3697\" title=\"AVP\" src=\"https:\/\/www.e-algos.com\/wp-content\/uploads\/2011\/11\/AVP.jpg\" alt=\"\" width=\"300\" height=\"200\" \/><\/a>ALISO VIEJO, Calif.,  Nov. 3, 2011 \/PRNewswire\/ &#8212;  <strong>Avanir Pharmaceuticals, Inc. <\/strong>(NASDAQ:  AVNR) \u03b1\u03bd\u03b1\u03ba\u03bf\u03af\u03bd\u03c9\u03c3\u03b5 \u03c3\u03ae\u03bc\u03b5\u03c1\u03b1 \u03c4\u03b7\u03bd \u03b5\u03b3\u03b3\u03c1\u03b1\u03c6\u03ae \u03c4\u03bf\u03c5 \u03c0\u03c1\u03ce\u03c4\u03bf\u03c5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ae \u03c3\u03c4\u03b7 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 PRIME.\u0397 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 PRIME \u03b5\u03af\u03bd\u03b1\u03b9 \u03bc\u03b9\u03b1 \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03b4\u03b5\u03cd\u03c4\u03b5\u03c1\u03b7\u03c2 \u03c6\u03ac\u03c3\u03b7 (\u0399\u0399) \u03c0\u03bf\u03c5 \u03b4\u03b9\u03b5\u03c1\u03b5\u03c5\u03bd\u03ac \u03c4\u03b7 \u03c7\u03c1\u03ae\u03c3\u03b7 \u03c4\u03bf\u03c5 \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03bf\u03c5 AVP-923 \u03b3\u03b9\u03b1 \u03c4\u03b7 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03c4\u03bf\u03c5 \u03ba\u03b5\u03bd\u03c4\u03c1\u03b9\u03ba\u03bf\u03cd \u03bd\u03b5\u03c5\u03c1\u03bf\u03c0\u03b1\u03b8\u03b7\u03c4\u03b9\u03ba\u03bf\u03cd \u03c0\u03cc\u03bd\u03bf\u03c5 \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03c3\u03ba\u03bb\u03ae\u03c1\u03c5\u03bd\u03c3\u03b7 \u03ba\u03b1\u03c4\u03ac \u03c0\u03bb\u03ac\u03ba\u03b1\u03c2 (MS). \u00ab\u03a0\u03b5\u03c1\u03af\u03c0\u03bf\u03c5 400.000 \u03ac\u03bd\u03b8\u03c1\u03c9\u03c0\u03bf\u03b9 \u03c3\u03c4\u03b9\u03c2 \u0397\u03a0\u0391 \u03c0\u03ac\u03c3\u03c7\u03bf\u03c5\u03bd \u03b1\u03c0\u03cc \u03c3\u03ba\u03bb\u03ae\u03c1\u03c5\u03bd\u03c3\u03b7 \u03ba\u03b1\u03c4\u03ac \u03c0\u03bb\u03ac\u03ba\u03b1\u03c2, \u03c5\u03c0\u03ac\u03c1\u03c7\u03b5\u03b9 \u03c3\u03b1\u03c6\u03ae\u03c2 \u03b1\u03bd\u03ac\u03b3\u03ba\u03b7 \u03b3\u03b9\u03b1 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03ad\u03c2 \u03ba\u03b1\u03b9 \u03b1\u03c3\u03c6\u03b1\u03bb\u03b5\u03af\u03c2 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b5\u03c2 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03b1\u03bd\u03c4\u03b9\u03bc\u03b5\u03c4\u03ce\u03c0\u03b9\u03c3\u03b7 \u03c3\u03c5\u03bc\u03c0\u03c4\u03c9\u03bc\u03ac\u03c4\u03c9\u03bd \u03c0\u03bf\u03c5 \u03c3\u03c7\u03b5\u03c4\u03af\u03b6\u03bf\u03bd\u03c4\u03b1\u03b9 \u03bc\u03b5 \u03c4\u03b7\u03bd \u03b1\u03c3\u03b8\u03ad\u03bd\u03b5\u03b9\u03b1 \u03b1\u03c5\u03c4\u03ae, \u03cc\u03c0\u03c9\u03c2 \u03c4\u03bf\u03c5 \u03ba\u03b5\u03bd\u03c4\u03c1\u03b9\u03ba\u03bf\u03cd \u03bd\u03b5\u03c5\u03c1\u03bf\u03c0\u03b1\u03b8\u03b7\u03c4\u03b9\u03ba\u03bf\u03cd \u03c0\u03cc\u03bd\u03bf\u03c5\u00bb, \u03b4\u03ae\u03bb\u03c9\u03c3\u03b5 \u03bf \u0386\u03bd\u03c4\u03c1\u03b9\u03bf\u03c5 \u0393\u03ba\u03bf\u03cd\u03bd\u03c4\u03bc\u03b1\u03bd, MD, \u039a\u03b1\u03b8\u03b7\u03b3\u03b7\u03c4\u03ae\u03c2 \u039d\u03b5\u03c5\u03c1\u03bf\u03bb\u03bf\u03b3\u03af\u03b1\u03c2 \u03c3\u03c4\u03bf \u03a0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03ae\u03bc\u03b9\u03bf \u03c4\u03bf\u03c5 \u03a1\u03cc\u03c4\u03c3\u03b5\u03c3\u03c4\u03b5\u03c1.<\/p>\n<p>\u00ab\u039f \u03bd\u03b5\u03c5\u03c1\u03bf\u03c0\u03b1\u03b8\u03b7\u03c4\u03b9\u03ba\u03cc\u03c2 \u03c0\u03cc\u03bd\u03bf\u03c2 \u03c0\u03b1\u03c1\u03b1\u03bc\u03ad\u03bd\u03b5\u03b9 \u03c7\u03c9\u03c1\u03af\u03c2 \u03c3\u03b7\u03bc\u03b1\u03bd\u03c4\u03b9\u03ba\u03ae \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03b3\u03b9\u03b1 \u03c0\u03bf\u03bb\u03bb\u03bf\u03cd\u03c2 \u03b1\u03bd\u03b8\u03c1\u03ce\u03c0\u03bf\u03c5\u03c2 \u03bc\u03b5 \u03c3\u03ba\u03bb\u03ae\u03c1\u03c5\u03bd\u03c3\u03b7 \u03ba\u03b1\u03c4\u03ac \u03c0\u03bb\u03ac\u03ba\u03b1\u03c2 \u03ba\u03b1\u03b9 \u03b4\u03b9\u03b1\u03c4\u03b1\u03c1\u03ac\u03c3\u03c3\u03b5\u03b9 \u03c3\u03b7\u03bc\u03b1\u03bd\u03c4\u03b9\u03ba\u03ac \u03c4\u03b7\u03bd \u03ba\u03b1\u03b8\u03b7\u03bc\u03b5\u03c1\u03b9\u03bd\u03ae \u03bb\u03b5\u03b9\u03c4\u03bf\u03c5\u03c1\u03b3\u03af\u03b1 \u03c4\u03c9\u03bd \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd.\u00bb<\/p>\n<p>\u0397 Avanir \u03b1\u03bd\u03b1\u03bc\u03ad\u03bd\u03b5\u03b9 \u03bd\u03b1 \u03b5\u03b3\u03b3\u03c1\u03b1\u03c6\u03bf\u03cd\u03bd \u03c0\u03b5\u03c1\u03af\u03c0\u03bf\u03c5 400 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03c4\u03cc\u03c3\u03bf \u03c3\u03c4\u03b9\u03c2 \u0397\u03a0\u0391 \u03cc\u03c3\u03bf \u03ba\u03b1\u03b9 \u03b4\u03b9\u03b5\u03b8\u03bd\u03ce\u03c2.<\/p>\n<p>\u03a3\u03b7\u03bc\u03b5\u03af\u03c9\u03c3\u03b7: \u0397 \u03b4\u03bf\u03c3\u03bf\u03bb\u03bf\u03b3\u03af\u03b1 \u03c4\u03c9\u03bd 20mg \u03c3\u03b5 \u03ba\u03ac\u03c8\u03bf\u03c5\u03bb\u03b1 \u03c4\u03bf\u03c5 AV-923 \u03ad\u03c7\u03b5\u03b9 \u03ae\u03b4\u03b7 \u03b5\u03b3\u03ba\u03c1\u03b9\u03b8\u03b5\u03af \u03b1\u03c0\u03cc \u03c4\u03bf\u03bd \u039f\u03c1\u03b3\u03b1\u03bd\u03b9\u03c3\u03bc\u03cc \u03a4\u03c1\u03bf\u03c6\u03af\u03bc\u03c9\u03bd \u03ba\u03b1\u03b9 \u03a6\u03b1\u03c1\u03bc\u03ac\u03ba\u03c9\u03bd \u03c4\u03b7\u03c2 \u0391\u03bc\u03b5\u03c1\u03b9\u03ba\u03ae\u03c2 (FDA) \u03c5\u03c0\u03cc \u03c4\u03bf \u03cc\u03bd\u03bf\u03bc\u03b1 NUEDEXTA\u00ae \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03c4\u03b7\u03c2 \u03c8\u03b5\u03c5\u03b4\u03bf\u03c0\u03c1\u03bf\u03bc\u03b7\u03ba\u03b9\u03ba\u03ae\u03c2 \u03c3\u03c5\u03bd\u03b4\u03c1\u03bf\u03bc\u03ae\u03c2.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ALISO VIEJO, Calif., Nov. 3, 2011 \/PRNewswire\/ &#8212; Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) \u03b1\u03bd\u03b1\u03ba\u03bf\u03af\u03bd\u03c9\u03c3\u03b5 \u03c3\u03ae\u03bc\u03b5\u03c1\u03b1 \u03c4\u03b7\u03bd \u03b5\u03b3\u03b3\u03c1\u03b1\u03c6\u03ae \u03c4\u03bf\u03c5 \u03c0\u03c1\u03ce\u03c4\u03bf\u03c5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ae \u03c3\u03c4\u03b7 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 PRIME.\u0397 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 PRIME \u03b5\u03af\u03bd\u03b1\u03b9 \u03bc\u03b9\u03b1 \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03b4\u03b5\u03cd\u03c4\u03b5\u03c1\u03b7\u03c2 \u03c6\u03ac\u03c3\u03b7 (\u0399\u0399) \u03c0\u03bf\u03c5 \u03b4\u03b9\u03b5\u03c1\u03b5\u03c5\u03bd\u03ac \u03c4\u03b7 \u03c7\u03c1\u03ae\u03c3\u03b7 \u03c4\u03bf\u03c5 \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03bf\u03c5 AVP-923 \u03b3\u03b9\u03b1 \u03c4\u03b7 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03c4\u03bf\u03c5 \u03ba\u03b5\u03bd\u03c4\u03c1\u03b9\u03ba\u03bf\u03cd \u03bd\u03b5\u03c5\u03c1\u03bf\u03c0\u03b1\u03b8\u03b7\u03c4\u03b9\u03ba\u03bf\u03cd \u03c0\u03cc\u03bd\u03bf\u03c5 \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03c3\u03ba\u03bb\u03ae\u03c1\u03c5\u03bd\u03c3\u03b7 \u03ba\u03b1\u03c4\u03ac \u03c0\u03bb\u03ac\u03ba\u03b1\u03c2 (MS). \u00ab\u03a0\u03b5\u03c1\u03af\u03c0\u03bf\u03c5 400.000 [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":5153,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[139],"tags":[],"class_list":["post-5240","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-139"],"_links":{"self":[{"href":"https:\/\/e-algos.com\/el\/wp-json\/wp\/v2\/posts\/5240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/e-algos.com\/el\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/e-algos.com\/el\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/e-algos.com\/el\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/e-algos.com\/el\/wp-json\/wp\/v2\/comments?post=5240"}],"version-history":[{"count":1,"href":"https:\/\/e-algos.com\/el\/wp-json\/wp\/v2\/posts\/5240\/revisions"}],"predecessor-version":[{"id":5241,"href":"https:\/\/e-algos.com\/el\/wp-json\/wp\/v2\/posts\/5240\/revisions\/5241"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/e-algos.com\/el\/wp-json\/wp\/v2\/media\/5153"}],"wp:attachment":[{"href":"https:\/\/e-algos.com\/el\/wp-json\/wp\/v2\/media?parent=5240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/e-algos.com\/el\/wp-json\/wp\/v2\/categories?post=5240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/e-algos.com\/el\/wp-json\/wp\/v2\/tags?post=5240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}